These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3544704)
1. Biological functions of serine proteases in the granules of rat mast cells. Katunuma N; Fukusen N; Kido H Adv Enzyme Regul; 1986; 25():241-55. PubMed ID: 3544704 [TBL] [Abstract][Full Text] [Related]
2. Biological functions of serine proteases in mast cells in allergic inflammation. Katunuma N; Kido H J Cell Biochem; 1988 Dec; 38(4):291-301. PubMed ID: 2467915 [TBL] [Abstract][Full Text] [Related]
3. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions. Kido H; Fukusen N; Katunuma N Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754 [TBL] [Abstract][Full Text] [Related]
4. Tryptase in rat mast cells: properties and inhibition by various inhibitors in comparison with chymase. Muramatu M; Itoh T; Takei M; Endo K Biol Chem Hoppe Seyler; 1988 Jul; 369(7):617-25. PubMed ID: 3066368 [TBL] [Abstract][Full Text] [Related]
5. Compound 48/80-induced secretion of histamine from rat peritoneal mast cells depends on a tryptase controlled step also leading to chymase activity. Vassimon CS; Rothschild AM Agents Actions; 1990 Apr; 30(1-2):150-2. PubMed ID: 1695438 [TBL] [Abstract][Full Text] [Related]
6. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. Goldstein SM; Leong J; Schwartz LB; Cooke D J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203 [TBL] [Abstract][Full Text] [Related]
7. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. He S; Gaça MD; Walls AF Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285 [TBL] [Abstract][Full Text] [Related]
8. Antibody and inhibitor of chymase inhibit histamine release in immunoglobulin E-activated mast cells. Kido H; Fukusen N; Katunuma N Biochem Int; 1985 Jun; 10(6):863-71. PubMed ID: 2412558 [TBL] [Abstract][Full Text] [Related]
9. Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines. Caughey GH; Lazarus SC; Viro NF; Gold WM; Nadel JA Immunology; 1988 Feb; 63(2):339-44. PubMed ID: 3127330 [TBL] [Abstract][Full Text] [Related]
10. Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut. Osman IA; Garrett JR; Smith RE J Histochem Cytochem; 1989 Apr; 37(4):415-21. PubMed ID: 2647838 [TBL] [Abstract][Full Text] [Related]
11. Tryptase from rat mast cells converts bovine prothrombin to thrombin. Kido H; Fukusen N; Katunuma N; Morita T; Iwanaga S Biochem Biophys Res Commun; 1985 Oct; 132(2):613-9. PubMed ID: 3904753 [TBL] [Abstract][Full Text] [Related]
13. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils. Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148 [TBL] [Abstract][Full Text] [Related]
15. Kinetic studies on the inhibitions of mast cell chymase by natural serine protease inhibitors: indications for potential biological functions of these inhibitors. Fukusen N; Kato Y; Kido H; Katunuma N Biochem Med Metab Biol; 1987 Oct; 38(2):165-9. PubMed ID: 3479119 [TBL] [Abstract][Full Text] [Related]
16. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. Caughey GH; Leidig F; Viro NF; Nadel JA J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273 [TBL] [Abstract][Full Text] [Related]
17. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors. Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542 [TBL] [Abstract][Full Text] [Related]
18. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G. He S; McEuen AR; Blewett SA; Li P; Buckley MG; Leufkens P; Walls AF Biochem Pharmacol; 2003 Mar; 65(6):1007-15. PubMed ID: 12623133 [TBL] [Abstract][Full Text] [Related]
19. Roles of mast cell tryptase and chymase in airway function. Caughey GH Am J Physiol; 1989 Aug; 257(2 Pt 1):L39-46. PubMed ID: 2669522 [TBL] [Abstract][Full Text] [Related]
20. Peptide boronic acids, substrate analogs, inhibit chymase, and histamine release from rat mast cells. Kato Y; Kido H; Fukusen N; Katunuma N J Biochem; 1988 May; 103(5):820-2. PubMed ID: 2460436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]